Investor Home

Stock Quote
MNOV (Common)
ExchangeNASDAQ (US Dollar)
Price$5.20
Change (%) Stock is Down 0.2 (3.70%)
Volume700
Data as of 09/03/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Corporate Profile
MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet need with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, ... More >>
Recent NewsMore >>
MediciNova to Present at the Rodman and Renshaw Annual Global Investment Conference - 09/02/10
SAN DIEGO, Sep 2, 2010 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today an... More >>
MediciNova Reports Second Quarter 2010 Results - 08/16/10
SAN DIEGO, Aug 16, 2010 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today a... More >>
MediciNova Announces Estimated Timing of Payments to Former Avigen Stockholders - 07/12/10
SAN DIEGO, Jul 12, 2010 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today a... More >>
Insight on MediciNova's MN-166 Mechanism of Action Reported in Proceedings of the National Academy of Sciences - 07/07/10
SAN DIEGO, Jul 7, 2010 (GlobeNewswire via COMTEX) --MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today reported that... More >>
MediciNova Nets $9.5 Million From Settlement of Auction Rate Securities Held by UBS - 07/06/10
SAN DIEGO, Jul 6, 2010 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today an... More >>
MediciNova Appoints Michael Coffee as Chief Business Officer - 06/14/10
SAN DIEGO, Jun 14, 2010 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today an... More >>
MediciNova Reports First Quarter 2010 Results - 05/17/10
SAN DIEGO, May 17, 2010 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today a... More >>
MediciNova Secures $15 Million Debt Facility From Oxford Finance Corporation - 05/11/10
SAN DIEGO, May 11, 2010 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today an... More >>
MediciNova Releases Notice of Pendency and Settlement of Class Action - 04/23/10
SAN DIEGO, Apr 23, 2010 (BUSINESS WIRE) --MediciNova, Inc., a biopharmaceutical company publicly traded on the Nasdaq Global Market (NASDAQ: MNOV) and the Hercules Market of the Osaka Securities Exchange (OSAKA: 4875), today releases ... More >>
The Clinical Potential and Therapeutic Differentiation of MediciNova's MN-166 Featured in Neurology Articles - 04/01/10
SAN DIEGO, Apr 1, 2010 (GlobeNewswire via COMTEX) --MediciNova, Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today reported th... More >>
Upcoming EventsMore >>
DateTitle
09/13/10 3:40 p.m. ET
MEDICINOVA INC at Rodman & Renshaw Global Investment Conference
LocationThe Palace Hotel
New York, NY US
What's New
There are currently no items available.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Medicinova Inc posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Investor Tools

Print Page Print Page
E-mail Page E-mail Page
RSS Feeds RSS Feeds
E-mail Alerts E-mail Alerts
IR Contacts IR Contacts


Stock Information

MNOV (Common)
$5.20   - 0.2		09/03/10
4:00 p.m. ET

Medicinova